A METHOD OF PREDICTING RESPONSE TO TREATMENT WITH A DISEASE-MODIFYING ANTI-RHEUMATIC DRUG, AND/OR CLASSIFYING DISEASE ACTIVITY IN A SUBJECT WITH RHEUMATOID ARTHRITIS

David Gibson; Tony Bjourson; Amanda Eakin; Philip Gardiner; Gary Wright; Naomi Todd

A METHOD OF PREDICTING RESPONSE TO TREATMENT WITH A DISEASE-MODIFYING ANTI-RHEUMATIC DRUG, AND/OR CLASSIFYING DISEASE ACTIVITY IN A SUBJECT WITH RHEUMATOID ARTHRITIS

David Gibson (Inventor), Tony Bjourson (Inventor), Amanda Eakin (Inventor), Philip Gardiner (Inventor), Gary Wright (Inventor), Naomi Todd (Inventor)

Research output: Patent

Abstract

The present invention relates to a method of predicting response to treatment with a disease-modifying anti-rheumatic drug, and/or classifying disease activity in a subject with rheumatoid arthritis by determining the quantitative level of one or more biomarkers and either predicting response to treatment with a disease-modifying anti-rheumatic drug, classifying disease activity, and/or predicting response to treatment with a disease-modifying anti-rheumatic drug and classifying disease activity.

Original language	English
Patent number	WO2021260180A1
IPC	C12Q1/6883
Priority date	25/06/20
Filing date	25/06/21
Publication status	Published (in print/issue) - 30 Dec 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://worldwide.espacenet.com/patent/search/family/071949804/publication/WO2021260180A1?q=pn%3DWO2021260180A1

Cite this

Gibson, D., Bjourson, T., Eakin, A., Gardiner, P., Wright, G., & Todd, N. (2021). A METHOD OF PREDICTING RESPONSE TO TREATMENT WITH A DISEASE-MODIFYING ANTI-RHEUMATIC DRUG, AND/OR CLASSIFYING DISEASE ACTIVITY IN A SUBJECT WITH RHEUMATOID ARTHRITIS. (Patent No. WO2021260180A1). https://worldwide.espacenet.com/patent/search/family/071949804/publication/WO2021260180A1?q=pn%3DWO2021260180A1

@misc{654e5037c4bb4bd986c026dd2ab6eccf,

title = "A METHOD OF PREDICTING RESPONSE TO TREATMENT WITH A DISEASE-MODIFYING ANTI-RHEUMATIC DRUG, AND/OR CLASSIFYING DISEASE ACTIVITY IN A SUBJECT WITH RHEUMATOID ARTHRITIS",

abstract = "The present invention relates to a method of predicting response to treatment with a disease-modifying anti-rheumatic drug, and/or classifying disease activity in a subject with rheumatoid arthritis by determining the quantitative level of one or more biomarkers and either predicting response to treatment with a disease-modifying anti-rheumatic drug, classifying disease activity, and/or predicting response to treatment with a disease-modifying anti-rheumatic drug and classifying disease activity.",

author = "David Gibson and Tony Bjourson and Amanda Eakin and Philip Gardiner and Gary Wright and Naomi Todd",

year = "2021",

month = dec,

day = "30",

language = "English",

type = "Patent",

note = "WO2021260180A1; C12Q1/6883",

}

Gibson, D , Bjourson, T, Eakin, A, Gardiner, P, Wright, G & Todd, N Dec. 30 2021, A METHOD OF PREDICTING RESPONSE TO TREATMENT WITH A DISEASE-MODIFYING ANTI-RHEUMATIC DRUG, AND/OR CLASSIFYING DISEASE ACTIVITY IN A SUBJECT WITH RHEUMATOID ARTHRITIS, Patent No. WO2021260180A1. <https://worldwide.espacenet.com/patent/search/family/071949804/publication/WO2021260180A1?q=pn%3DWO2021260180A1>

TY - PAT

T1 - A METHOD OF PREDICTING RESPONSE TO TREATMENT WITH A DISEASE-MODIFYING ANTI-RHEUMATIC DRUG, AND/OR CLASSIFYING DISEASE ACTIVITY IN A SUBJECT WITH RHEUMATOID ARTHRITIS

AU - Gibson, David

AU - Bjourson, Tony

AU - Eakin, Amanda

AU - Gardiner, Philip

AU - Wright, Gary

AU - Todd, Naomi

PY - 2021/12/30

Y1 - 2021/12/30

N2 - The present invention relates to a method of predicting response to treatment with a disease-modifying anti-rheumatic drug, and/or classifying disease activity in a subject with rheumatoid arthritis by determining the quantitative level of one or more biomarkers and either predicting response to treatment with a disease-modifying anti-rheumatic drug, classifying disease activity, and/or predicting response to treatment with a disease-modifying anti-rheumatic drug and classifying disease activity.

AB - The present invention relates to a method of predicting response to treatment with a disease-modifying anti-rheumatic drug, and/or classifying disease activity in a subject with rheumatoid arthritis by determining the quantitative level of one or more biomarkers and either predicting response to treatment with a disease-modifying anti-rheumatic drug, classifying disease activity, and/or predicting response to treatment with a disease-modifying anti-rheumatic drug and classifying disease activity.

M3 - Patent

M1 - WO2021260180A1

Y2 - 2021/06/25

ER -

A METHOD OF PREDICTING RESPONSE TO TREATMENT WITH A DISEASE-MODIFYING ANTI-RHEUMATIC DRUG, AND/OR CLASSIFYING DISEASE ACTIVITY IN A SUBJECT WITH RHEUMATOID ARTHRITIS

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this